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Abstract
Basaloid squamous cell carcinoma (BSCC) is a rare and aggressive variant of squamous cell
carcinoma (SCC) that occurs preferentially in the upper aerodigestive tract. We present two cases
of BSCC, one arising in the conjunctiva and the other arising in a paranasal sinus. Clinical and
pathological findings in these two cases, including immunohistochemistry is presented along with
brief discussion of literature. To the best of our knowledge, this is the first report of BSCC of the
conjunctiva. BSCC of the head and neck should be distinguished from adenoid cystic carcinoma,
small cell neuroendocrine carcinoma, basal cell adenocarcinoma, adenosquamous carcinoma,
squamous cell carcinoma, spindle cell squamous carcinoma, mucoepidermoid carcinoma, and
adenoid cystic carcinoma.
Introduction
Basaloid squamous cell carcinoma (BSCC) was first
described in the upper aerodigestive tract by Wain et al [1]
in 1986. BSCC is characterized by nesting, Lobular and
trabecular arrangement of small crowded cells with scant
cytoplasm, and hyperchromatic nuclei. The lobules of
malignant basaloid cells often display peripheral nuclear
palisading, high mitotic activity, comedo necrosis, and
small cystic spaces filled with mucinous material, making
these tumors difficult to differentiate from adenoid cystic
carcinoma or from small-cell undifferentiated carcinoma.
The most common sites to be affected are larynx,
hypopharynx, tonsils and the base of tongue. Other less
frequently affected sites are nose, paranasal sinus, external
ear, submandibular region, esophagus, lung, anus, vulva,
vagina and the uterine cervix. So far, only 21 cases of
BSCC of the nose and paranasal sinuses have been
reported in the English literature [2]. To our best knowl-
edge, this tumor has not been reported in the conjunctiva.
Case Reports
Our first case was a 64-year-old Caucasian Canadian male
who presented with an eyelid mass. On examination, it
was found to be arising from the palpebral conjunctiva. A
biopsy was taken from the tumor and interpreted initially
as basal cell carcinoma. This was followed by wider exci-
sion following review of pathology at our institution. Past
medical history was unremarkable. The second case was a
previously healthy 60-year-old female who presented
with epistaxis, pain and mass in the right nasal cavity and
paranasal sinus. Preoperatively, the mass was found to be
arising from the anterior end of right middle turbinate of
the nasal cavity. It was clinically thought to be a hemangi-
oma. There was no significant history of smoking or alco-
hol consumption in either case. There was no evidence of
either lymphatic or distant metastasis at the time of diag-
nosis. The second case showed a low absolute lymphocyte
count.
Microscopic examination of both cases showed tumour
cells arranged in ribbons, trabeculae and islands. There
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were two types of tumour cells. The predominant cell pop-
ulation was that of basaloid, closely apposed cells with
scanty cytoplasm and hyperchromatic nuclei. Nucleoli
were variable. Islands of tumour cells showing peripheral
palisading and central necrosis were noted in case 1 (Fig-
ure 1). There was an abrupt association of these basaloid
cells with rare squamous foci (Figure 2). Some multinu-
cleated giant cells containing intracellular keratin were
also seen. Many apoptotic cells and mitotic figures,
including atypical mitosis were present. Tumour was seen
to arise from the surface epithelium which was focally
dysplastic (Figure 3). Few rosette-like structures were
noted in case 1. Many thin walled blood filled channels as
well as areas of hemorrhage were present in case 2. The
immnoprofile of these tumours showed diffuse positive
staining for squamous epithelial marker 34βE12 (Figure
4) and are negative for other markers for small cell neu-
roendocrine tumours and myoepithelial markers seen in
adenoid cystic carcinoma. In addition these lesions were
positive for EMA marker (Figure 5) and negative for
BerEP4 and BCL2 which were helpful to differentiate
these tumours from BCC. The conjuctival lesion was
treated with wider excision and follow up. The patient
with the nasal BSCC was treated by surgical excision of the
mass together with anterior end of the middle nasal tur-
binate in October 2007, followed by radiotherapy. At last
follow-up, 19 months after surgery, the patient exhibited
no evidence of recurrent disease or regional lymph node
metastases.
Discussion
BSCC is a rare variant of squamous cell carcinoma which
occurs predominantly in men in their 60 and 70s. There
have been some reports of it being associated with
tobacco and alcohol abuse [2]. It arises in a variety of ana-
tomic sites, most frequently in the upper aero-digestive
tract with strong predilection for the base of the tongue,
supraglottic larynx and hypopharynx, but is also found in
the anus, thymus and uterine cervix. Clinically, it is an
aggressive tumor with high rates of nodal (64%) and dis-
tant metastasis (44%). Results of a case-control study by
Soriano et al [3] found a 6 times higher risk of distant
metastasis compared to usual type of SCC. Some authors,
therefore, recommend a chest CT and FDG-PET in all
cases to rule out early distant metastasis. Treatment of
choice is complete surgical excision supplemented by
radiotherapy/adjuvant chemotherapy. Nasal BSCC usu-
ally presents as either an obstructive mass or pain.
Microphotograph of BSCC showing islands of tumor cells  with peripheral palisading and central necrosis Figure 1
Microphotograph of BSCC showing islands of tumor 
cells with peripheral palisading and central necrosis.
Microphotograph of BSCC showing squamous cells nesting Figure 2
Microphotograph of BSCC showing squamous cells 
nesting.
Bssc with surface epithelial dysplasia Figure 3
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Wieneke et al [4] studied 14 cases of BSCC of the sinona-
sal tract. All their reported cases demonstrated surface epi-
thelial dysplasia, however there was no evidence of
multifocal disease. In addition, to the usual morphologi-
cal features of BSCC they found neural type rosettes
arrangement. Both of our cases corroborate their findings.
Due to its biphasic nature, BSCC may not be recognized if
the minor squamoid component is overlooked or not
sampled, especially in small biopsies. BSCC needs to be
differentiated from tumours such as adenoid cystic carci-
noma (ACC) [5], as it carries a poorer prognosis and has
different management regimes. BSCC may have PAS pos-
itive microcystic spaces similar to the characteristic
punched out spaces of ACC. However, ACC often has less
pleomorphism, mitosis and necrosis than BSCC. There is
no dysplasia or continuity of tumor with the surface epi-
thelium in adnexal tumors such as ACC. It is important to
distinguish BSCC from small cell neuroendocrine carci-
noma (SCNC) because of the difference in treatment for
these two tumors. Both tumors may show sheets of small
blue cells and rosette like structures (Figure 3). However,
SCNC shows characteristic nuclear molding and crushing
artifact, and is rarely connected to surface mucosa. Basal
cell carcinoma is extremely rare primary conjuctival tumor
[6]. However, BCC arising from eyelid skin with direct
spread to conjuctival mucosa needs to be considered in
the differential diagnosis of the first case. The BCCs are
made up of nests of basaloid cells with peripherally pal-
isading cells. The cells have hyperchromatic nuclei and
scant cytoplasm. The nests of tumor cells are surrounded
by stroma. Retraction spaces can usually be observed
between the islands and stroma. Ulcerations may be seen
in large tumors, but no dysplasia of the surface epithe-
lium. BSCC is distinguished on the basis of histologic
inspection by lobules, nests, and cribriform patterns of
basaloid cells that commonly have abrupt foci of squa-
mous differentiation within the nests. Necrosis is typical,
taking the form of single cell necrosis and central comedo
necrosis. The second major characteristic of the BSCC is
the presence of squamous component that includes at
least one of following features: adjacent foci of conven-
tional squamous cell carcinoma, dysplasia or carcinoma
in situ of the overlying mucosa. In the large majority of
cases, the distinction between these two tumours is read-
ily made on the basis of standard H&E morphology. How-
ever, application of immunohistochemical markers is
useful to differentiate these tumors. BCCs are negative for
EMA, and are positive for BCL2 and 2 Ber-EP4. The cells
in BSCC are positive for 34βE12 and EMA and focally pos-
itive for CEA [7]. The lesion was clinically conjunctival in
origin and associated with surface epithelial dysplasia,
and pathologically supported by immunohistochical
application fulfills the features of BSCC. To our knowl-
edge this represents the first case of BSCC to be reported
in the conjunctiva.
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